1. Academic Validation
  2. CP-66,948: an antisecretory histamine H2-receptor antagonist with mucosal protective properties

CP-66,948: an antisecretory histamine H2-receptor antagonist with mucosal protective properties

  • Dig Dis Sci. 1991 Dec;36(12):1721-8. doi: 10.1007/BF01296616.
J P Hakkinen 1 W F Holt C J Goddard P J Oates W R Murphy J J Maciejko L A Reiter
Affiliations

Affiliation

  • 1 Department of Metabolic Diseases, Central Research Division, Pfizer Inc., Groton, CT 06340.
Abstract

CP-66,948 is a histamine H2-receptor antagonist with gastric antisecretory activity and mucosal protective properties. The affinity of CP-66,948 for the guinea pig atria histamine H2-receptor is 15 times greater than that of cimetidine and seven times greater than that of ranitidine. In vivo, the ED50 value for inhibition of gastric acid secretion in pylorus-ligated rats is 2 mg/kg intraduodenally, and in histamine or pentagastrin-stimulated Heidenhain pouch dogs the antisecretory ED50 values are 0.3 mg/kg per os and 1.0 mg/kg per os, respectively. CP-66,948 also inhibits ethanol-induced gastric hemorrhagic lesions in rats following either oral or systemic administration (ED50 values of 12 mg/kg per os and 6 mg/kg subcutaneously). In addition, the mucosal protective activity is independent of prostaglandin synthesis. CP-66,948 inhibits gastric acid secretion in man, and its mucosal protective activity may provide additional benefits in peptic ulcer therapy.

Figures
Products